Orchestra Biomed Holdings Stock Market Value
| OBIO Stock | 5.57 0.20 3.47% |
| Symbol | Orchestra |
Orchestra BioMed Holdings Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orchestra BioMed. If investors know Orchestra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orchestra BioMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.60) | Revenue Per Share 0.073 | Quarterly Revenue Growth 1.356 | Return On Assets (0.39) | Return On Equity (0.92) |
The market value of Orchestra BioMed Holdings is measured differently than its book value, which is the value of Orchestra that is recorded on the company's balance sheet. Investors also form their own opinion of Orchestra BioMed's value that differs from its market value or its book value, called intrinsic value, which is Orchestra BioMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orchestra BioMed's market value can be influenced by many factors that don't directly affect Orchestra BioMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orchestra BioMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orchestra BioMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orchestra BioMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Orchestra BioMed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Orchestra BioMed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Orchestra BioMed.
| 01/06/2023 |
| 11/26/2024 |
If you would invest 0.00 in Orchestra BioMed on January 6, 2023 and sell it all today you would earn a total of 0.00 from holding Orchestra BioMed Holdings or generate 0.0% return on investment in Orchestra BioMed over 690 days. Orchestra BioMed is related to or competes with BCE, CECO Environmental, Freedom Internet, Iridium Communications, Century Aluminum, Sphere Entertainment, and Maanshan Iron. Orchestra BioMed is entity of United States More
Orchestra BioMed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Orchestra BioMed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Orchestra BioMed Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 25.42 | |||
| Value At Risk | (7.67) | |||
| Potential Upside | 7.24 |
Orchestra BioMed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Orchestra BioMed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Orchestra BioMed's standard deviation. In reality, there are many statistical measures that can use Orchestra BioMed historical prices to predict the future Orchestra BioMed's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.92) | |||
| Treynor Ratio | (0.07) |
Orchestra BioMed Holdings Backtested Returns
Orchestra BioMed Holdings maintains Sharpe Ratio (i.e., Efficiency) of -0.0225, which implies the firm had a -0.0225% return per unit of risk over the last 3 months. Orchestra BioMed Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orchestra BioMed's Risk Adjusted Performance of (0.01), variance of 24.77, and Coefficient Of Variation of (3,626) to confirm the risk estimate we provide. The company holds a Beta of 2.21, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Orchestra BioMed will likely underperform. At this point, Orchestra BioMed Holdings has a negative expected return of -0.11%. Please make sure to check Orchestra BioMed's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Orchestra BioMed Holdings performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.33 |
Poor reverse predictability
Orchestra BioMed Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between Orchestra BioMed time series from 6th of January 2023 to 17th of December 2023 and 17th of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Orchestra BioMed Holdings price movement. The serial correlation of -0.33 indicates that nearly 33.0% of current Orchestra BioMed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.33 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 1.81 |
Orchestra BioMed Holdings lagged returns against current returns
Autocorrelation, which is Orchestra BioMed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Orchestra BioMed's stock expected returns. We can calculate the autocorrelation of Orchestra BioMed returns to help us make a trade decision. For example, suppose you find that Orchestra BioMed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Orchestra BioMed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Orchestra BioMed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Orchestra BioMed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Orchestra BioMed stock over time.
Current vs Lagged Prices |
| Timeline |
Orchestra BioMed Lagged Returns
When evaluating Orchestra BioMed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Orchestra BioMed stock have on its future price. Orchestra BioMed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Orchestra BioMed autocorrelation shows the relationship between Orchestra BioMed stock current value and its past values and can show if there is a momentum factor associated with investing in Orchestra BioMed Holdings.
Regressed Prices |
| Timeline |
Pair Trading with Orchestra BioMed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orchestra BioMed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will appreciate offsetting losses from the drop in the long position's value.Moving against Orchestra Stock
| 0.32 | A | Agilent Technologies Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Orchestra BioMed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orchestra BioMed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orchestra BioMed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orchestra BioMed Holdings to buy it.
The correlation of Orchestra BioMed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orchestra BioMed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orchestra BioMed Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orchestra BioMed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Orchestra BioMed Correlation, Orchestra BioMed Volatility and Orchestra BioMed Alpha and Beta module to complement your research on Orchestra BioMed. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Orchestra BioMed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.